Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
159.5 GBX | +2.90% | +6.33% | -47.70% |
03/05 | Kelso raises stake in NCC; Transense joins project | AN |
30/04 | Faron Pharmaceuticals Ltd. Announces Appointment of Dr. Juho Jalkanen as Director | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.70% | 140M | |
+2.97% | 108B | |
+10.21% | 104B | |
+1.75% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- FARN Stock
- News Faron Pharmaceuticals Oy
- Faron Halts Investigational COVID-19 Therapy Trial Due to Low Infection, Hospitalization Rates